Not applicableActive Not RecruitingNCT05571618What this trial is testingThe Rechallenge of ADCs in MBC PatientsWho this might be right forBreast Cancer Fudan University 100
Large-scale testing (Phase 3)WithdrawnNCT03811418What this trial is testingCompare Pertuzumab + Trastuzumab + Vinorelbine vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-positive Metastatic Breast CancerWho this might be right forAdvanced Breast CancerHER2-positive Breast Cancer iOMEDICO AG
Not applicableStudy completedNCT00096590What this trial is testingDetecting Abnormal Blood Clotting in Patients With Metastatic Cancer Undergoing SurgeryWho this might be right forThromboembolismUnspecified Adult Solid Tumor, Protocol Specific National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT03641313What this trial is testingBerzosertib and Irinotecan in Treating Patients With Progressive, Metastatic, or Unresectable TP53 Mutant Gastric or Gastroesophageal Junction CancerWho this might be right forClinical Stage III Gastric Cancer AJCC v8Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage IV Gastric Cancer AJCC v8+5 more National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Study completedNCT00267020What this trial is testingPhase 2 Study of Gemcitabine or Gemcitabine + Enzastaurin in Participants With Advanced or Metastatic Pancreatic CancerWho this might be right forPancreatic Neoplasm Eli Lilly and Company 130
Testing effectiveness (Phase 2)Ended earlyNCT00496379What this trial is testingZK219477 (Sagopilone) in Patients With Breast Cancer and Brain MetastasesWho this might be right forBreast CancerCNS Disease Nancy Lin, MD 15
Not applicableUnknownNCT02103179What this trial is testingVEGF Signaling Promotes Cell Growth and Metastasis in Extrahepatic Cholangiocarcinoma in a VEGF Receptor Mediated Pathway (ECC)Who this might be right forExtrahepatic Cholangiocarcinoma First Affiliated Hospital, Sun Yat-Sen University 20
Not applicableStudy completedNCT00410579What this trial is testingPatient-Reported Outcomes in Long-Term Survivors of Colon and Rectal CancersWho this might be right forColorectal CancerFatigueLong-term Effects Secondary to Cancer Therapy in Adults+2 more NSABP Foundation Inc 744
Testing effectiveness (Phase 2)Study completedNCT03520842What this trial is testingRegorafenib and Methotrexate in Treating Participants With Recurrent or Metastatic KRAS Mutated Non-Small Cell Lung CancerWho this might be right forKRAS Gene MutationMetastatic Malignant Neoplasm in the BrainRecurrent Non-Small Cell Lung Carcinoma+1 more Stanford University 22
Testing effectiveness (Phase 2)UnknownNCT04572542What this trial is testingCamrelizumab Combined With Apatinib Mesylate Tablets and Nab-paclitaxel in the Second-line Treatment of Advanced Gastric CancerWho this might be right forLocally Advanced or Metastatic Gastric Adenocarcinoma The First Affiliated Hospital of Xiamen University 46
Testing effectiveness (Phase 2)Study completedNCT02536742What this trial is testingPalbociclib in Molecularly Characterized ER-positive/HER2-negative Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer ETOP IBCSG Partners Foundation 124
Testing effectiveness (Phase 2)UnknownNCT05131386What this trial is testingMulticohort Trial of Trabectedin and Low-dose Radiation Therapy in Advanced/Metastatic SarcomasWho this might be right forSoft Tissue SarcomaBone TumorsSmall Round-cell Sarcomas Grupo Espanol de Investigacion en Sarcomas 85
Early research (Phase 1)Study completedNCT01513083What this trial is testingTrastuzumab Emtansine in Patients With HER2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic FunctionWho this might be right forBreast Cancer Hoffmann-La Roche 28
Testing effectiveness (Phase 2)Ended earlyNCT00632541What this trial is testingA Phase II Study of Bevacizumab + Sorafenib in Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer Hoosier Cancer Research Network 18
Large-scale testing (Phase 3)Study completedNCT03306394What this trial is testingTrifluridine/Tipiracil (Also Known as S 95005 or TAS-102) in Patients With a Pretreated Colorectal Cancer That Has Spread (Metastatic).Who this might be right forMetastatic Colorectal Cancer Institut de Recherches Internationales Servier 907
Early research (Phase 1)Study completedNCT05735366What this trial is testingSAIL66 in Patients With CLDN6-positive Locally Advanced or Metastatic Solid TumorsWho this might be right forSolid Tumor Chugai Pharmaceutical 22
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06752408What this trial is testingAumolertinib Versus Osimertinib As First-line Therapy for Patients with EGFR Mutated Locally Advanced or Metastatic Non-small-cell Lung CancerWho this might be right forNon Small Cell Lung Cancer Peking Union Medical College Hospital 316
Early research (Phase 1)Ended earlyNCT00747825What this trial is testingPhase I Safety and Dosimetry Study in Patients With Confirmed Metastatic MelanomaWho this might be right forMetastatic Melanoma Molecular Insight Pharmaceuticals, Inc. 12
Early research (Phase 1)Study completedNCT00112476What this trial is testingTemsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid TumorsWho this might be right forRecurrent MelanomaRecurrent Renal Cell CancerStage IV Melanoma+2 more National Cancer Institute (NCI) 24
Large-scale testing (Phase 3)Study completedNCT00384176What this trial is testingFirst Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOXWho this might be right forColorectal Cancer AstraZeneca 1,814